Meghan McGarry, MD, MS

Dr. McGarry is a Pediatric Pulmonologist who researches cystic fibrosis. Her main focus is researching health disparities in cystic fibrosis, particularly in minorities. She is conducting a cohort study of lung function in Latinos/Hispanics with cystic fibrosis. She also does research in diversity in clinical trials in cystic fibrosis.

Dr. McGarry studied Biology at Whitworth College. She then attended University of Washington School of Medicine, working in many underserved regions from Alaska to Zambia. She completed her Pediatric residency at Rainbow Babies and Children's Hospital. She completed her Pediatric Pulmonary and Pediatric Clinical Pharmacology Fellowships at University of California San Francisco. She also completed her Masters in Clinical Research at University of California San Francisco.
Education
Masters Clinical Research, 2015 - , University of California San Francisco
Pediatric Pulmonology, 2015 - , University of California San Francisco
Pediatric Residency, 2012 - , Rainbow Babies and Children's Hospital
M.D., 2009 - , University of Washington
BS Biology, 2005 - , Whitworth College
Honors and Awards
  • K Boost Award, Cystic Fibrosis Foundation, 2020-2023
  • K23 Career Development Award, NHLBI, 2018-2023
  • Jane Addams Social Justice Award, UCSF, 2017
  • Harry Schwachman Cystic Fibrosis Clinical Scholar, Cystic Fibrosis Foundation, 2016-2019
  • ATS International Conference Pediatric Abstract Scholarship, American Thoracic Society, 2016
  • Walter Travel Grant, Breathe California, 2015
  • Best Research, Fellows Poster Presentation, California Thoracic Society, 2015
  • ATS International Conference Pediatric Abstract Scholarship, American Thoracic Society, 2014
  • Fellow’s Scholarship, California CF Consortium, 2014
  • Pediatric Clinical Pharmacology, Drug Action, and Pharmacogenetics T32, NICHD/NIGMS, 2013-2016
  • Fellow’s Scholarship, California CF Consortium, 2013
  • Resident Teacher of the Year, Rainbow Babies and Children’s Hospital, 2010
Websites

  1. McGarry ME, Sciortino S, Graham S, Bishop T, Gibb ER. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities. Pediatric pulmonology 2024. PMID: 38940324


  2. Green DM, Lahiri T, Raraigh KS, Ruiz F, Spano J, Antos N, Bonitz L, Christon L, Gregoire-Bottex M, Hale JE, Langfelder-Schwind E, La Parra Perez Á, Maguiness K, Massie J, McElroy-Barker E, McGarry ME, Mercier A, Munck A, Oliver KE, Self S, Singh K, Smiley M, Snodgrass S, Tluczek A, Tuley P, Lomas P, Wong E, Hempstead SE, Faro A, Ren CL. Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID. Pediatrics 2024. PMID: 38577740


  3. Vaziri S, McGarry ME, Huang CY, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP. Time to be blunt: Substance use in cystic fibrosis. Pediatric pulmonology 2024. PMID: 38251844


  4. Stoffella S, Ly N, McGarry M, Neemuchwala F, Church G, Chan M, Cuneo A, Omori M, Gibb E. Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report. Pediatric pulmonology 2023. PMID: 38088240


  5. McGarry ME, Huang CY, Ly NP. Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2023. PMID: 37460380


  6. Sun Y, Chiou SH, Wu CO, McGarry M, Huang CY. DYNAMIC RISK PREDICTION TRIGGERED BY INTERMEDIATE EVENTS USING SURVIVAL TREE ENSEMBLES. The annals of applied statistics 2023. PMID: 37284167


  7. McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT. How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis. Pediatric pulmonology 2023. PMID: 36722731


  8. Smith MA, Dinh D, Ly NP, Ward SL, McGarry ME, Zinter MS. Changes in the Use of Invasive and Noninvasive Mechanical Ventilation in Pediatric Asthma: 2009-2019. Annals of the American Thoracic Society 2023. PMID: 36315585


  9. McGarry ME, Ren CL, Wu R, Farrell PM, McColley SA. Detection of disease-causing CFTR variants in state newborn screening programs. Pediatric pulmonology 2022. PMID: 36237137


  10. McGarry ME, McColley SA, Taylor-Cousar J. In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies". Respiratory medicine 2022. PMID: 36049345


  11. Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME. Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households. 2022. PMID: 35112507


  12. McGarry ME, Gibb ER, Oates GR, Schechter MS. Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis. 2021. PMID: 35277357


  13. McGarry ME, McColley SA. Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype. Pediatric pulmonology 2021. PMID: 33470563


  14. McGarry ME, Huang CY, Nielson DW, Ly NP. Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020. PMID: 33162303


  15. Smith MA, McGarry ME, Ly NP, Zinter MS. Outcomes of Children With Cystic Fibrosis Admitted to PICUs. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2020. PMID: 32304511


  16. McGarry M. Transparency and diversity in cystic fibrosis research. Lancet (London, England) 2020. PMID: 32861304


  17. McGarry ME. Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. The New England journal of medicine 2020. PMID: 32053310


  18. McGarry ME, Williams WA, McColley SA. The demographics of adverse outcomes in cystic fibrosis. Pediatric pulmonology 2019. PMID: 31715087


  19. Zeiger AM, McGarry ME, Mak ACY, Medina V, Salazar S, Eng C, Liu AK, Oh SS, Nuckton TJ, Jain D, Blackwell TW, Kang HM, Abecasis G, Oñate LC, Seibold MA, Burchard EG, Rodriguez-Santana J. Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico. Pediatric pulmonology 2019. PMID: 31665830


  20. McGarry ME, Neuhaus JM, Nielson DW, Ly NP. Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States. Pediatric pulmonology 2019. PMID: 31144477


  21. Zinter MS, Dvorak CC, Mayday MY, Iwanaga K, Ly NP, McGarry ME, Church GD, Faricy LE, Rowan CM, Hume JR, Steiner ME, Crawford ED, Langelier C, Kalantar K, Chow ED, Miller S, Shimano K, Melton A, Yanik GA, Sapru A, DeRisi JL. Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. PMID: 30239621


  22. Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, Rodriguez-Santana JR, Ford JG, Chapela R, Estrada AM, Sandoval K, Seibold MA, Winkler CA, Bleecker ER, Myers DA, Williams LK, Hernandez RD, Torgerson DG, Burchard EG. A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. The pharmacogenomics journal 2018. PMID: 30206298


  23. Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, McGarry M, Moreno-Estrada A, Sandoval K, Winkler CA, Seibold MA, Padhukasahasram B, Conti DV, Farber HJ, Avila P, Brigino-Buenaventura E, Lenoir M, Meade K, Serebrisky D, Borrell LN, Rodriguez-Cintron W, Thyne S, Joubert BR, Romieu I, Levin AM, Sienra-Monge JJ, Del Rio-Navarro BE, Gan W, Raby BA, Weiss ST, Bleecker E, Meyers DA, Martinez FJ, Gauderman WJ, Gilliland F, London SJ, Bustamante CD, Nicolae DL, Ober C, Sen S, Barnes K, Williams LK, Hernandez RD, Burchard EG. An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos. The Journal of allergy and clinical immunology 2018. PMID: 30201514


  24. McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatric pulmonology 2017. PMID: 29082671


  25. McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies. Pediatric pulmonology 2017. PMID: 28068001


  26. Oh SS, Du R, Zeiger AM, McGarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Eng C, Nishimura KK, Huntsman S, Farber HJ, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne SM, Sen S, Rodriguez-Santana JR, Williams K, Kumar R, Burchard EG. Breastfeeding associated with higher lung function in African American youths with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma 2016. PMID: 27929698


  27. McGarry ME, McColley SA. Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis. Annals of the American Thoracic Society 2016. PMID: 27410177


  28. McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, Sen S, Rodriguez-Santana JR, Borrell LN, Burchard EG. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest 2015. PMID: 25742612


  29. Thakur N, McGarry ME, Oh SS, Galanter JM, Finn PW, Burchard EG, ATS Health Equality Committee. The lung corps' approach to reducing health disparities in respiratory disease. Annals of the American Thoracic Society 2014. PMID: 24697756


  30. McGarry ME, Nielson DW. Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N. Chest 2013. PMID: 24081349